SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 9 March, 2026 0

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Dr. Andrés Rodríguez - 4 March, 2026 0

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Dr. Omar Tupayachi - 3 March, 2026 0

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: bivalirudin

STEACS and the Use of Bivalirudin vs. Heparin: In Search of...

ESC 2018 | MATRIX: 1-Year Superiority of Transradial Access

VALIDATE-SWEDEHEART: bivalirudin seems to be losing ground

Transradial access shows no benefit of bivalirudin

Bivalirudin reduces bleeding rate in carotid stenting

Cardiovascular Events Reduction: Bivalirudin or Heparin?

No Extra Benefit for Combined Use of Bivalirudin and Transradial Approach

New Meta-Analysis Shows Similar Mortality between Bivalirudin and Heparin

Bivalirudin could be beneficial in peripheral PCI

Últimas Noticias

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Noticias Institucionales

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

Fellow’s Corner 2026 – Submit Your Clinical Case

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

Accesos